RxDoctor Payments Data

Martin Quirno, MD

Orthopaedic Surgery of the Spine · New York, NYNPI 1285883330

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $44,450 of the $55,513 with a category attached, or 80.1%. Zimvie Inc. accounts for 82.2% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2022 at $23,735 and has fallen 99.0% since, to $227 in 2025.

$55,513in general payments, 2019–2025

Across 136 payments — averaging $408.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimvie Inc.$46K
  • Depuy Synthes Products, Inc.$7K
  • Johnson & Johnson$733
  • Medical Device Business Services, Inc.$380
  • Globus Medical$371
  • Zimmer Biomet$364
  • plus $833 from 9 others

What the payments were for

  • Consulting fees$44,45080%
  • Speaking & faculty fees$2,4004%
  • Travel & lodging$4,9999%
  • Food & beverage$3,6657%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$55,513 in reported general payments places this provider in the 70th percentile of 161 orthopaedic surgery of the spine providers in New York.

See all orthopaedic surgery of the spine providers in New York

Medicare billing

Part B allowed, 2024
$25,396
Medicare patients
76
Services billed
194

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone15$133

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →